Text Size: A A A      Contrast:        Transparency in Coverage Rule

Dr. Singerman interviewed by Channel 3 News about new AMD eyedrops study

Dr. Singerman was interviewed by Monica Robins from Channel 3 WKYC in Cleveland about a new eye drops study for treating wet AMD and the role of Retina Associates as the only clinical center in Ohio.

Retina Associates of Cleveland, Inc. (RACI) has secured 1 of only 21 clinical trial locations across the U.S. set to begin Phase II evaluation of a promising new treatment for wet AMD, Squalamine Eye Drops made by Ohr Pharmaceutical.  RACI will be the only clinical site in the state of Ohio offering the new drops to qualified patients enrolled in the randomized, double blind, placebo controlled study evaluating the safety and efficacy of the new treatment and its success in combating the progression of wet AMD.

Here's a link to the news story which aired March 9th, 2013 during the 9am News: